The role of general practitioners in diagnosis of cutaneous melanoma: A population-based study in France

British Journal of Dermatology

Volumn 167, Issue 6, 2012, Pages 1351-1359

  Grange, F ^a   Barbe, C ^b   Mas, L ^a   Granel Brocard, F ^c   Lipsker, D ^d   Aubin, F ^e   Velten, M ^f   Dalac, S ^g   Truchetet, F ^h   Michel, C ⁱ   Mitschler, A ^j   Arnoult, G ^b   Buemi, A ^k   Dalle, S ^l   Reuter, G ^m   Bernard, P ^a   Woronoff, A S ⁿ   Arnold, F ^o  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c CHU NANCY BRABOIS   (France)

^d HÔPITAL CIVIL   (France)

^e HÔPITAL SAINT JACQUES   (France)

^f Registre des Cancers du Bas Rhin and Reseau Francais des Registres de Cancers (FRANCIM)   (France)

^g HÔPITAL DU BOCAGE   (France)

^h centre hospitalier de Montbrison   (France)

ⁱ Hôpital du Moenschberg   (France)

^j Pasteur Hospital   (France)

^k Registre des Cancers du Haut Rhin and Réseau Français des Registres de Cancers FRANCIM   (France)

^l HÔTEL DIEU   (France)

^m Cabinet de Dermatologie   (France)

ⁿ UNIVERSITY HOSPITAL OF BESANÇON   (France)

^o Association Departementale des Professions de Sante Pour le Depistage des Cancers   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BRESLOW THICKNESS; CANCER REGISTRY; CHILD; CLINICAL PRACTICE; CUTANEOUS MELANOMA; FEMALE; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCHOOL CHILD; SKIN EXAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FRANCE; GENERAL PRACTITIONERS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S ROLE; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84870253489     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11178.x     Document Type: Review

References (29)

1. MacKie RM, Hole D, Hunter JA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ 1997; 315: 1117-21.
2. Grange F,. [Epidemiology of cutaneous melanoma: descriptive data in France and Europe]. Ann Dermatol Venereol 2005; 132: 975-82. (in French)
3. Ferlay J, Parkin DM, Steliarova-Foucher E,. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81.
4. Garbe C, Leiter U,. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
5. Geller AC, O'Riordan DL, Oliveria SA, et al. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract 2004; 17: 416-23.
6. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000; 89: 280-5.
7. Oliveria SA, Heneghan MK, Cushman LF, et al. Skin cancer screening by dermatologists, family practitioners, and internists: barriers and facilitating factors. Arch Dermatol 2011; 147: 39-44.
8. Grange F, Hédelin G, Halna J-M, et al. [Assessment of a general practitioner training campaign for early detection of cutaneous melanoma in the Haut-Rhin department of France]. Ann Dermatol Venereol 2005; 132: 956-61, (in French).
9. Geller AC, Swetter SM, Oliveria S, et al. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol 2011; 5 (Suppl. 1): S87-94.
10. Khorshid SM, Pinney E, Bishop JA,. Melanoma excision by general practitioners in north-east Thames region, England. Br J Dermatol 1998; 138: 412-17.
11. Brady MS, Oliveria SA, Christos PJ, et al. Patterns of detection in patients with cutaneous melanoma. Cancer 2000; 89: 342-7.
12. Baade PD, Youl PH, English DR, et al. Clinical pathways to diagnose melanoma: a population-based study. Melanoma Res 2007; 17: 243-9.
13. Pennie ML, Soon SL, Risser JB, et al. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 2007; 143: 488-94.
14. Barbe C, Hibon E, Vitry F, et al. Clinical and pathological characteristics of melanoma: a population-based study in a French regional population. J Eur Acad Dermatol Venereol 2012; 26: 159-64.
15. Durbec F, Vitry F, Granel-Brocard F, et al. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol 2010; 146: 240-6.
16. Terushkin V, Halpern AC,. Melanoma early detection. Hematol Oncol Clin North Am 2009; 23: 481-500, viii.
17. Carli P, De Giorgi V, Palli D, et al. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study. Dermatol Surg 2004; 30: 1371-5; discussion 1375-6.
18. Baumert J, Plewig G, Volkenandt M, Schmid-Wendtner M-H,. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007; 156: 938-44.
19. Nagore E, Oliver V, Botella-Estrada R, et al. Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness. Acta Derm Venereol 2006; 86: 50-6.
20. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000; 89: 271-9.
21. Geller AC, Elwood M, Swetter SM, et al. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia. Cancer 2009; 115: 1318-27.
22. Chamberlain AJ, Fritschi L, Giles GG, et al. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002; 138: 609-14.
23. Lipsker D, Engel F, Cribier B, et al. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157: 338-43.
24. Durbec F, Martin L, Derancourt C, Grange F,. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol 2012; 166: 727-39.
25. Geller AC, Johnson TM, Miller DR, et al. Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 2009; 145: 409-14.
26. McPherson M, Elwood M, English DR, et al. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 2006; 54: 783-92.
27. Youl PH, Baade PD, Janda M, et al. Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary care skin cancer clinic doctors? Med J Aust 2007; 187: 215-20.
28. Van Durme DJ, Ferrante JM, Pal N, et al. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med 2000; 9: 606-11.
29. Grange F, Vitry F, Granel-Brocard F, et al. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol 2008; 144: 629-36.